AIM2 and renal carcinoma: CCK‐8 assays demonstrated that Ad‐CAIXpromotor‐AIM2 remarkably reduced the proliferation of renal carcinoma cells at time‐dependent (Figure 3C,D), and this reduced proliferation was stronger on OSRC‐2 cells than that in 786‐O cells.